Professor Meghan Morrissey earns an innovation award to program immune cells to attack cancer tumors. #immunotherapy ...

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.

Some oncologists suggest that, for certain early cancers not at risk of spreading, the term “cancer” should be avoided.

An immunotherapy combination for advanced, highly mutated colorectal cancer (CRC) significantly slowed disease progression ...

First-line treatment with targeted therapies plus chemotherapy offered overall response benefits in BRAF V600E-mutant ...

In pancreatic cancer, pelareorep previously demonstrated a strong efficacy signal when administered with gemcitabine, nab-paclitaxel and atezolizumab. Our new safety data indicate its ability to also ...

The aging population and lifestyle-related factors contribute to a surge in pancreatic cancer cases. The aggressive nature of the disease and its high mortality rate demand innovative therapies.

According to the American Cancer Society's annual report, there was a 34% decrease in deaths between 1991 and 2022. While ...

Cancer incidence continues to rise for many common cancers—especially for women. The incidence rate for women younger than 50 ...

The acquisition of IDRx will help GSK target a ‘major gap in the current standard of care’ related to gastrointestinal ...

according to the American Cancer Society. GSK’s acquisition of IDRx will include IDRX-42 which is currently being developed and trialled as therapy for the treatment of gastrointestinal stomal ...